Home » Newsletters » BioWorld Science

BioWorld Science

June 27, 2007

View Archived Issues

AS-605858: A selective PI3K gamma inhibitor for the treatment of inflammatory conditions

Health Canada approves Astellas' antifungal treatment Mycamine

Injection of the GAD gene into the brain is safe in Parkinson's disease patients

New approaches in the management of bipolar disorder

ICAgen and McNeil terminate senicapoc collaboration

Metabasis Therapeutics initiates phase Ib trial of MB-07811 for hyperlipidemia

Ceregene and Genzyme establish CERE-120 partnership

GPC Biotech licenses satraplatin to Yakult for Japan

Rotigotine beneficial in restless legs syndrome, Parkinson's disease studies

Levetiracetam evaluated in children with ADHD and restless legs syndrome

Pregabalin improves sleep in fibromyalgia patients

Interferon beta-1a reduces fatigue in multiple sclerosis patients

Roche's emerging franchise in RA now includes Toyama Chemical's T-5224

TransOral changes name to Transcept

SkyePharma Inc. changes name to Pacira

Cytokinetics and GSK extend research term under collaboration

New phase II trial studies Cotara in glioblastoma multiforme

Corlux mitigates weight gain associated with olanzapine

Encouraging data for NG2-73 in chronic insomnia

Modigene develops long-acting, proprietary versions of approved therapeutic proteins

Revlimid receives full E.U. approval for multiple myeloma

Four-type human papillomavirus vaccine Gardasil recommended worldwide

Recent GSK patent discloses novel therapeutic agents for gastrointestinal disorders

Recent Cytopia patent divulges new immunosuppressant agents

Recent patents disclose novel agents for obesity and lipoprotein metabolism disorders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...